glp 1 drug How long should you take GLP-1 drugs? Study links longer use to lower heart risk Study: Popular GLP-1 Drug May

GLP-1 receptor agonists act on the pancreas by enhancing insulin secretion, inhibiting glucagon release (see #4 below), and there is some evidence to suggest that they protect the beta cells from damage

[DOI] [PMC free article] [PubMed] [Google Scholar] 80.Dore DD, Bloomgren GL, Wenten M, Hoffman C, Clifford CR, Quinn SG, Braun DK, Noel RA, Seeger JD

Scoping studies: towards a methodological framework

This can exacerbate pre-existing deficiencies common in individuals with obesity and diabetes, such as low iron, vitamin D, or zinc

Eduard Vieta has received grants and served as consultant, advisor or CME speaker for the following entities: AB-Biotics, Abbott, AbbVie, Adamed, Alcediag, Angelini, Biogen, Beckley-Psytech, Biohaven, Boehringer-Ingelheim, Casen-Recordati, Celon Pharma, Clariane, Compass, Dainippon Sumitomo Pharma, Esteve, Ethypharm, Ferrer, Gedeon Richter, GH Research, Glaxo-Smith Kline, HMNC, Intra-Cellular therapies, Idorsia, Johnson & Johnson, Lundbeck, Luye Pharma, Medincell, Merck, Mitsubishi Tanabe Pharma, Newraxpharm, Newron, Novartis, Organon, Orion Corporation, Otsuka, Roche, Rovi, Sage, Sanofi-Aventis, Sunovion, Takeda, Teva, and Viatris, outside the submitted work